Orchid Pharma Limited (ORCHPHARMA) — Announcement | 7 April 2026

StockFin.ai

Try Free

💡 Investor Takeaway
Review the full filing details on NSE or company channels to identify any material impacts on investment thesis.

Orchid Pharma Limited filed a general corporate document on the NSE. Without access to the specific filing content, the exact nature of the disclosure—whether operational updates, financial results, regulatory compliance, or strategic announcements—cannot be determined. Investors should review the complete filing on the NSE website or the company's investor relations portal to assess any material developments affecting shareholder interests.

📄 View Original Announcement (PDF)

📊 Stock Analysis — ORCHPHARMA ✨ Ask AI About This

About Orchid Pharma Limited (ORCHPHARMA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹3,614.24 Cr P/E: 32.3

View full ORCHPHARMA stock details →

📡 Get AI alerts when ORCHPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ORCHPHARMA — Free

💡 Ask AI about this filing

"How does this affect ORCHPHARMA margins?" "Compare with last quarter results" "What should investors watch for?"

Ask AI Free →

📊 More ORCHPHARMA filings

See all ORCHPHARMA filings →

🔥 Also filed on 7 April 2026

CMPDI Central Mine Planning & Design Institute Limited Announcement AGSTRA AGS Transact Technologies Limited Announcement MAHLIFE Mahindra Lifespace Developers Limited Announcement SRF SRF Limited Announcement DCMSRIND DCM Shriram Industries Limited Corporate Action RELIGARE Religare Enterprises Limited Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when ORCHPHARMA files new disclosures

Track ORCHPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track ORCHPHARMA — Free

Free account · 2 AI queries/day